| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Non-US | 6.5 | 5.6 | 6.5 | 9.0 | | | | |
| Other | 55.4 | 56.6 | 54.8 | 54.4 | | | | |
| Revenues [+] | 61.9 | 62.2 | 61.3 | 63.4 | 57.3 | 53.3 | 55.4 | 54.2 |
| Products | 61.9 | 62.2 | 61.3 | 63.4 | 57.3 | 53.3 | 55.4 | 54.2 |
| Revenue growth [+] | -0.4% | 1.5% | -3.3% | 10.6% | 7.5% | -3.7% | 2.1% | 3.5% |
| Non-US | 16.4% | -13.7% | -27.7% | | | | | |
| Cost of goods sold | 64.4 | 59.5 | 58.5 | 65.0 | 53.6 | 46.5 | 46.4 | 45.6 |
| Gross profit | -2.4 | 2.7 | 2.8 | -1.6 | 3.7 | 6.8 | 8.9 | 8.5 |
| Gross margin | -3.9% | 4.4% | 4.6% | -2.5% | 6.5% | 12.7% | 16.1% | 15.8% |
| Selling, general and administrative [+] | 21.1 | 24.1 | 30.0 | 23.1 | 23.3 | 21.1 | 19.1 | 18.3 |
| Sales and marketing | 5.7 | 7.9 | 9.1 | 1.0 | | | | |
| General and administrative | 15.3 | 16.2 | 21.0 | 22.1 | | | | |
| Research and development | 6.8 | 7.1 | 6.9 | 5.6 | 6.3 | 5.8 | 5.0 | 7.8 |
| Other operating expenses | | | 0.4 | 1.0 | 0.0 | | | |
| EBITDA [+] | -29.7 | -27.6 | -33.7 | -30.7 | -25.4 | -19.4 | -14.3 | -16.6 |
| EBITDA growth | 7.5% | -18.2% | 9.9% | 20.8% | 30.7% | 36.2% | -13.8% | -64.0% |
| EBITDA margin | -47.9% | -44.4% | -55.0% | -48.4% | -44.3% | -36.5% | -25.8% | -30.6% |
| Depreciation and amortization | 0.7 | 0.8 | 0.8 | 0.7 | 0.5 | 0.8 | 0.8 | 1.0 |
| EBIT [+] | -30.3 | -28.4 | -34.5 | -31.3 | -25.9 | -20.2 | -15.1 | -17.6 |
| EBIT growth | 6.7% | -17.7% | 10.2% | 20.9% | 28.3% | 33.8% | -14.0% | -62.7% |
| EBIT margin | -49.0% | -45.7% | -56.3% | -49.4% | -45.2% | -37.9% | -27.3% | -32.4% |
| Non-recurring items [+] | | | | 1.1 | | | | |
| In-process research & development | | | | 1.1 | | | | |
| Interest expense, net [+] | 2.3 | 1.6 | -0.4 | -0.5 | -0.8 | -0.8 | -0.7 | 3.8 |
| Interest expense | 2.4 | 1.9 | 0.0 | | | | | 4.2 |
| Interest income | 0.0 | 0.2 | 0.4 | 0.5 | 0.8 | 0.8 | 0.7 | 0.4 |
| Other income (expense), net [+] | | -0.8 | 0.0 | -0.2 | -0.8 | | | |
| Gain (loss) on investments | | | | | -0.8 | | | |
| Litigation settlement | | | 0.4 | 1.0 | | | | |
| Gain (loss) on foreign currency transactions | | | | | 0.0 | | | |
| Change in fair value of warrants | | -0.8 | | | | | | |
| Other | -2.3 | -2.5 | 0.4 | | 0.0 | | | |
| Pre-tax income | -32.7 | -30.9 | -34.1 | -32.1 | -25.9 | -19.4 | -14.4 | -21.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% |
| Net income | -32.7 | -30.9 | -34.1 | -32.1 | -25.9 | -19.8 | -14.4 | -21.3 |
| Net margin | -52.8% | -49.7% | -55.7% | -50.7% | -45.2% | -37.2% | -26.1% | -39.4% |
| |
| Basic EPS [+] | ($0.35) | ($0.41) | ($0.56) | ($0.61) | ($0.51) | ($0.39) | ($0.29) | ($0.52) |
| Growth | -14.7% | -27.1% | -7.9% | 19.8% | 29.9% | 35.7% | -44.1% | -65.3% |
| Diluted EPS [+] | ($0.35) | ($0.41) | ($0.56) | ($0.61) | ($0.51) | ($0.39) | ($0.29) | ($0.52) |
| Growth | -14.7% | -27.1% | -7.9% | 19.8% | 29.9% | 35.7% | -44.1% | -65.3% |
| |
| Shares outstanding (basic) [+] | 93.8 | 75.6 | 60.9 | 52.8 | 51.1 | 50.7 | 50.1 | 41.4 |
| Growth | 24.0% | 24.1% | 15.3% | 3.4% | 0.8% | 1.2% | 20.9% | 25.9% |
| Shares outstanding (diluted) [+] | 93.8 | 75.6 | 60.9 | 52.8 | 51.1 | 50.7 | 50.1 | 41.4 |
| Growth | 24.0% | 24.1% | 15.3% | 3.4% | 0.8% | 1.2% | 20.9% | 25.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |